60 Degrees Pharmaceuticals Warrant
SXTPW
8 hedge funds and large institutions have $261K invested in 60 Degrees Pharmaceuticals Warrant in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
13.34% more ownership
Funds ownership: 0% → 13.34% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$132K |
| 2 |
Walleye Capital
New York
|
+$95.7K |
| 3 |
CS
Clear Street
New York
|
+$65.5K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$12.7K |
| 5 |
VF
Virtu Financial
New York
|
+$8.71K |
Top Sellers
SXTPW Hedge Fund Activity: Q3 2023 in Review
8 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q3 2023, worth a combined $261K.
Buyers outnumbered sellers: 8 funds opened new SXTPW positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $132K.
- 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $261K of 60 Degrees Pharmaceuticals Warrant stock for Q3 2023.
- 8 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q3 2023 and 0 closed out, a net change of +8 holders.
- The largest 60 Degrees Pharmaceuticals Warrant buyer in Q3 2023 was Sabby Management, an estimated $132K added.
Based on aggregated 13F filings for Q3 2023.